Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

por Feagan, B. G., Patel, H., Colombel, J.‐F., Rubin, D. T., James, A., Mody, R., Lasch, K.
Publicado 2016

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome

por Marquis, P, Lasch, K E, Delgado-Herrera, L, Kothari, S, Lembo, A, Lademacher, C, Spears, G, Nishida, A, Tesler, Waldman L, Piault, E, Rosa, K, Zeiher, B
Publicado 2014